Study protocol for a phase II, multicentre, prospective, non-randomised clinical trial to assess the safety and efficacy of infusing allogeneic activated and expanded natural killer cells as consolidation therapy for paediatric acute myeloblastic leukaemia

  1. Muñoz Builes, M.
  2. Vela Cuenca, M.
  3. Fuster Soler, J.L.
  4. Astigarraga, I.
  5. Pascual Martínez, A.
  6. Vagace Valero, J.M.
  7. Tong, H.Y.
  8. Valentín Quiroga, J.
  9. Fernández Casanova, L.
  10. Escudero López, A.
  11. Sisinni, L.
  12. Blanquer, M.
  13. Mirones Aguilar, I.
  14. González Martínez, B.
  15. Borobia, A.M.
  16. Pérez-Martínez, A.
Aldizkaria:
BMJ Open

ISSN: 2044-6055

Argitalpen urtea: 2020

Alea: 10

Zenbakia: 1

Mota: Artikulua

DOI: 10.1136/BMJOPEN-2019-029642 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus